EUVIMEDEUVIMED entdecken
Crossref

Non-neuronal ferroptosis in the central nervous system

Jack Winneberger, Lukas Raich, Tammo Potthast, Marcel S. Woo

Ferroptosis and Oxidative Stress · 2026

DOI: 10.70401/fos.2026.0030 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Ferroptosis and Oxidative Stress, 2026. Verfasst von Jack Winneberger und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ferroptosis, a lipid peroxidation-driven form of regulated cell death, has emerged as a central mechanism in neurological disease. While most studies have focused on neuronal vulnerability, non-neuronal cells, including oligodendrocytes, astrocytes, microglia, brain endothelial cells, and central nervous system (CNS) infiltrating T cells, play equally critical roles in shaping disease progression. These cell types regulate iron homeostasis, lipid metabolism, antioxidant defenses, and inflammatory signaling, thereby establishing the microenvironmental conditions that determine ferroptotic susceptibility within the CNS. Accumulating evidence demonstrates lipid peroxidation and ferroptosis-related signaling in demyelinating disorders, ischemic injury, small vessel disease, Alzheimer’s disease, Parkinson’s disease, and spinal cord injury. However, the contribution of non-neuronal cells to ferroptotic stress and execution remains comparatively underexplored. In this review, we synthesize emerging data highlighting cell type-specific dependencies on glutathione peroxidase 4 (GPX4), solute carrier family 7 member 11 (SLC7A11), ferroptosis suppressor protein 1 (FSP1), nuclear factor erythroid 2-related factor 2 (NRF2), peroxiredoxin (PRDX), thioredoxin (TRX), iron-handling proteins, and lipid remodeling pathways, and discuss how these regulatory networks differ across CNS-resident and CNS infiltrating T cells. We propose that ferroptosis in neurological disease is not solely a neuron-autonomous event, but a tissue-level process orchestrated by non-neuronal cells with distinct metabolic and immunological programs. Understanding these cell type-specific vulnerabilities and regulatory mechanisms will be essential for the development of targeted therapeutic strategies aimed at modulating ferroptotic stress in neuroinflammatory and neurodegenerative disorders.

Zitieren

APA

Winneberger, J., Raich, L., Potthast, T., & Woo, M. S. (2026). Non-neuronal ferroptosis in the central nervous system. Ferroptosis and Oxidative Stress. https://doi.org/10.70401/fos.2026.0030

Vancouver

Winneberger J, Raich L, Potthast T, Woo MS. Non-neuronal ferroptosis in the central nervous system. Ferroptosis and Oxidative Stress. 2026. doi:10.70401/fos.2026.0030

BibTeX
@article{Winneberger2026,
  author = {Winneberger, Jack and Raich, Lukas and Potthast, Tammo and Woo, Marcel S.},
  title = {Non-neuronal ferroptosis in the central nervous system},
  journal = {Ferroptosis and Oxidative Stress},
  year = {2026},
  doi = {10.70401/fos.2026.0030}
}
Kostenlos starten →